Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Immunophage Biotech
company
About
Immunophage Biotech is a Nanjing-based pharmaceutic company.
- 11 - 50
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $14.20M
- Industries
- Biotechnology,Pharmaceutical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Immunophage Biotech is a Chinese high-tech pharmaceutic company which was established in 2016. The R&D center of the company is located in the Pujiang High-Tech Park, Shanghai, China. They are developing first-in-class immune-regulating medicines against cancer, autoimmune diseases and neurodegenerative disorders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$14.20M
Immunophage Biotech has raised a total of
$14.20M
in funding over 2 rounds. Their latest funding was raised on
Sep 28, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 28, 2021 | Series A | — | 1 | — | — | Detail |
| May 5, 2020 | Seed | $14.20M | 6 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
7
Immunophage Biotech is funded by 7 investors.
Jinfang Hongrui Investment Management
and Renjin Ziben
are the most recent investors.
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
